Mobile App for Mental Health Monitoring and Clinical Outreach in Veterans: Mixed Methods Feasibility and Acceptability Study

Abstract

Background Advances in mobile health (mHealth) technology have made it possible for patients and health care providers to monitor and track behavioral health symptoms in real time. Ideally, mHealth apps include both passive and interactive monitoring and demonstrate high levels of patient engagement. Digital phenotyping, the measurement of individual technology usage, provides insight into individual behaviors associated with mental health. Objective Researchers at a Veterans Affairs Medical Center and Cogito Corporation sought to explore the feasibility and acceptability of an mHealth app, the Cogito Companion. Methods A mixed methodological approach was used to investigate the feasibility and acceptability of the app. Veterans completed clinical interviews and self-report measures, at baseline and at a 3-month follow-up. During the data collection period, participants were provided access to the Cogito Companion smartphone app. The mobile app gathered passive and active behavioral health indicators. Data collected (eg, vocal features and digital phenotyping of everyday social signals) are analyzed in real time. Passive data collected include location via global positioning system (GPS), phone calls, and SMS text message metadata. Four primary model scores were identified as being predictive of the presence or absence of depression or posttraumatic stress disorder (PTSD). Veterans Affairs clinicians monitored a provider dashboard and conducted clinical outreach when indicated. Results Findings suggest that use of the Cogito Companion app was feasible and acceptable. Veterans (n=83) were interested in and used the app; however, active use declined over time. Nonetheless, data were passively collected, and outreach occurred throughout the study period. On the Client Satisfaction Questionnaire–8, 79% (53/67) of the sample reported scores demonstrating acceptability of the app (mean 26.2, SD 4.3). Many veterans reported liking specific app features (day-to-day monitoring) and the sense of connection they felt with the study clinicians who conducted outreach. Only a small percentage (4/67, 6%) reported concerns regarding personal privacy. Conclusions Feasibility and acceptability of the Cogito Corporation platform to monitor mental health symptoms, behaviors, and facilitate follow-up in a sample of veterans were supported. Clinically, platforms such as the Cogito Companion system may serve as useful methods to promote monitoring, thereby facilitating early identification of risk and mitigating negative psychiatric outcomes, such as suicide.

Phenotypes of engagement with mobile health technology for heart rhythm monitoring

“…Measures of mHealth use over time show that many users discontinue use within 3–6 months of initiation. 9–11 In fact, digital phenotyping studies have reported variable levels of engagement with mHealth which hampers the feasibility of phenotyping work 12 , 13 and may impair accuracy. 14 Prior work has identified correlates of mHealth use over time but findings are inconsistent between studies.…”

Sensing Apps and Public Data Sets for Digital Phenotyping of Mental Health: Systematic Review

“…Cogito Companion [56] Mental state prediction Sleep, mobility, and sociability Virtual Strength Within Me [57] Mental state prediction It does not infer information Ambient EuStress [58] Mental state prediction Mobility and sociability Positioning, inertial, virtual, and ambient Mood Triggers [59] Mental state classification Physical activity and mobility Positioning and inertial Data Collector [60]…”

A Comparative Evaluation of Measurement-Based Psychiatric Care Delivered via Specialized Telemental Health Platform Versus Treatment As Usual: A Retrospective Analysis

“…Many of these tools empower patients by enabling them to track their progress and become active participants in their healthcare journeys [27]. Moreover, many apps serve as useful methods for monitoring and facilitating early identification of risk and thus help mitigate negative psychiatric outcomes [28].…”